You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCMA-CART

Showing 1 - 25 of 408
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Philadelphia (BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART

Active, not recruiting
  • Multiple Myeloma
  • BCMA CART + huCART19
  • +2 more
  • Philadelphia, Pennsylvania
    Univ. of Pennsylvania
Jul 11, 2022

Multiple Myeloma Trial in Zhengzhou (PD1-BCMA-CART)

Not yet recruiting
  • Multiple Myeloma
  • PD1-BCMA-CART
  • Zhengzhou, Henan, China
    First Affliated Hospital of Zhengzhou University
May 15, 2022

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023

Multiple Myeloma Trial in Hangzhou, Wuhan (CART-BCMA)

Recruiting
  • Multiple Myeloma
  • Hangzhou, China
  • +1 more
Apr 23, 2022

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

Recruiting
  • Multiple Myeloma
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023

Safety and Efficacy Trial in Suzhou (anti-CD19 and anti-BCMA CAR, Immunomodulatory drugs)

Recruiting
  • Safety and Efficacy
  • anti-CD19 and anti-BCMA CAR
  • Immunomodulatory drugs
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
May 17, 2021

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Multiple Myeloma Trial in Shanghai (GC012F injection)

Unknown status
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 21, 2021

Dose Escalation and Safety Trial in Jerusalem (CART BCMA)

Recruiting
  • Dose Escalation and Safety
  • CART BCMA
  • Jerusalem, Israel
    Hadassah University Hospital
Jan 21, 2021

Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Spain (ARI0003)

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • ARI0003
  • Santiago De Compostela, A Coruña, Spain
  • +6 more
Oct 24, 2023

Safety and Efficacy Trial in Suzhou (JWCAR129)

Recruiting
  • Safety and Efficacy
  • JWCAR129
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Dec 16, 2020

Multiple Myeloma Trial in Philadelphia (CART-BCMA)

Completed
  • Multiple Myeloma
  • CART-BCMA
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Aug 3, 2020

Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

Recruiting
  • Plasma Cell Leukemia
  • anti-BCMA CAR-T
  • VRD-based regimen
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Aug 4, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • VRD
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 5, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)

Recruiting
  • Multiple Myeloma
  • anti-BCMA CAR-T
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 4, 2023

Multiple Myeloma Trial in Boston, Milwaukee (CART-ddBCMA)

Not yet recruiting
  • Multiple Myeloma
  • CART-ddBCMA
  • Boston, Massachusetts
  • +1 more
Jul 7, 2022

Multiple Myeloma Trial in Suzhou (BCMA-CART cells)

Unknown status
  • Multiple Myeloma
  • BCMA-CART cells
  • Suzhou, Jiangsu, China
    Hematology Department of the Second Affiliated Hospital of Suzho
Dec 2, 2019

Multiple Myeloma Trial in Sanya (BCMA-PD1-CART Cell)

Recruiting
  • Multiple Myeloma
  • BCMA-PD1-CART Cell
  • Sanya, Hainan, China
    Hainan Hospital of Chinese PLA General Hospital
Nov 14, 2019

Multiple Myeloma Trial in Wuhan (SENL103)

Recruiting
  • Multiple Myeloma
  • SENL103
  • Wuhan, Hubei, China
    Tongji Hospital
Sep 27, 2023

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Multiple Myeloma Trial in Chicago, Boston, Milwaukee (PHE885)

Recruiting
  • Multiple Myeloma
  • PHE885
  • Chicago, Illinois
  • +4 more
Jul 28, 2022

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Multiple Myeloma Trial in Shanghai (Anti-BCMA CAR-T cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Anti-BCMA CAR-T cells
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Aug 29, 2021